Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Pentosan polysulfate sodium - bene-Arzneimittel/ReqMed

Drug Profile

Pentosan polysulfate sodium - bene-Arzneimittel/ReqMed

Alternative Names: AK-150; Elmiron; NaPPS

Latest Information Update: 29 Aug 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator bene-Arzneimittel; ReqMed
  • Developer Asahi Kasei; Bayer; bene-Arzneimittel; Multiplex Pharma Holdings; Ortho-McNeil Pharmaceutical; Teva Pharmaceutical Industries
  • Class Analgesics; Anti-inflammatories; Anticoagulants; Antihyperlipidaemics; Antiretrovirals; Antithrombotics; Antivirals; Glycosaminoglycans; Polymers; Polysaccharides; Small molecules; Sulfuric acids
  • Mechanism of Action Cell membrane permeability inhibitors; Non-nucleoside reverse transcriptase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Pain; Interstitial cystitis
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Marketed Pain
  • Registered Interstitial cystitis
  • Phase II Mucopolysaccharidosis I
  • Phase I/II Mucopolysaccharidosis VI
  • Discontinued Osteoarthritis; Spinal cord disorders

Most Recent Events

  • 08 May 2018 Consilient Health and bene-Arzneimittel GmbH signs distribution agreement to distribute Pentosan polysulfate sodium in the United Kingdom
  • 08 Feb 2018 Discontinued - Phase-II for Spinal cord disorders in Japan (SC)
  • 08 Dec 2017 Phase-II clinical trials in Osteoarthritis (In children) in Japan (SC) (UMIN000032119)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top